The DOI matches its Crossref record; 2 of the 2 references it cites were found in a registry or an index.
Molecular events associated with dysplastic morphologic transformation and initiation of ovarian tumorigenicity
Abstract
BACKGROUND: Disabled‐2 (Dab2), a candidate tumor suppressor of ovarian carcinoma, frequently (around 80%) loses its expression in ovarian tumors. Expression of exogenous Dab2 in tumor cell lines negatively regulates growth and suppresses the downstream signal of the Ras/mitogen activated protein kinase mitogenic pathway. The inactivation of Dab2 is believed to be an early event in ovarian tumorigenicity. METHODS: The authors analyzed the correlation among expression of Dab2, presence of basement membrane (collagen IV and laminin), morphologic alteration of the surface epithelial cells, and expression of the mitotic index marker Mib‐1 in 50 archived ovarian tumors by an immunohistochemical approach. The stainings of Dab2, Mib‐1, collagen IV, and laminin in premalignant lesions bordering both normal and neoplastic ovarian surface epithelium from adjacent slides were analyzed in 50 ovarian tumors. RESULTS: In these 50 ovarian tumors, the percentage of Mib‐1 positive tumor cells distributed in a wide range, from 1% to 75%, and there has no strong correlation with the expression of Dab2. However, in the premalignant regions bordering tumor and normal ovarian surface epithelium, the loss of Dab2 expression closely correlated with the dysplastic morphologic transition and Mib‐1 expression of the ovarian surface epithelial cells. In 20 foci in 12 out of the 50 tumors, a transition from normal to neoplastic morphology within a contiguous epithelium was observed, and in all cases the morphologic change correlated with the loss of Dab2 staining. In addition, the collagen and laminin staining of the basement membrane were absent or weakened in pre‐malignant epithelium prior to loss of Dab2 expression in all these 20 cases. Nevertheless, collagen IV and laminin were detectable in established adenomas on the same tumor slides. CONCLUSIONS: The loss of Dab2 is closely associated with the transition of ovarian surface epithelial cells to premalignant states and is likely involved in the initiation of ovarian tumorigenicity. Transient loss of collagen IV and laminin in the basement membrane of the premalignant epithelium and subsequent inactivation of Dab2 are common early events associated with tumorigenicity of the ovarian surface epithelium. Cancer 2002;94:2380–92. © 2002 American Cancer Society. DOI 10.1002/cncr.10497
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
Dab2 tumor suppressor function is attributed to epithelial organization.
“epithelial organization (Sheng et al., 2000b; Yang et al., 2002b, 2007)”
From Endocytosis and Physiology: Insights from Disabled-2 Deficient Mice (2016) · cites this paper as Yang et al., 2002b
Loss of Dab2 expression occurs in an epithelial layer and correlates closely with morphological transformation from a benign monolayer to malignant multiple layered ovarian cancer.
“A suggestive observation is that the loss of Dab2 expression occurs in an epithelial layer, and correlates closely with morphological transformation from a benign monolayer to malignant multiple layered ovarian cancer (Yang et al., 2002b).”
From Endocytosis and Physiology: Insights from Disabled-2 Deficient Mice (2016) · cites this paper as Yang et al., 2002b
Citations
Cites
Scrambler and yotari disrupt the disabled gene and produce a reeler -like phenotype in mice
Sheldon, M., Rice, D. S., D'Arcangelo, G., Yoneshima, H., Nakajima, K., Mikoshiba, K., Howell, B. W., Cooper, J. A., Goldowitz, D., & Curran, T. (1997) · Nature · doi:10.1038/39601 · Cited by 638
Drosophila abl and genetic redundancy in signal transduction
HOFFMANN, F. (1991) · Trends in Genetics · doi:10.1016/0168-9525(91)90254-f · Cited by 62
Flagged first, then by citations
Research works printed but not linked: 57
- 10.1002/cncr.2820710207 · DOI
- 10.1002/cncr.2820710426 · DOI
- 10.1007/978-1-4615-5447-9_2 · DOI
- 10.1016/0028-2243(85)90059-0 · DOI
- 10.1095/biolreprod44.4.717 · DOI
- 10.1016/S0140-6736(71)92335-X · DOI
- 10.1046/j.1365-2265.1998.00577.x · DOI
- 10.1016/S0140-6736(99)02250-3 · DOI
- 10.1093/jnci/84.8.592 · DOI
- Testa JR, 1994, Spontaneous transformation of rat ovarian surface epithelial cells results in well to poorly differentiated tumors with a parallel range of cytogenetic complexity, Cancer Res., 54, 2778
- 10.1002/jcb.240590928 · DOI
- 10.1046/j.1365-2559.2001.01042.x · DOI
- 10.1002/1097-0142(19940401)73:7<1859::AID-CNCR2820730714>3.0.CO;2-L · DOI
- 10.1093/jnci/88.24.1810 · DOI
- 10.1097/00004347-199301000-00008 · DOI
- Aoki Y, 2000, Early form of ovarian cancer originating in inclusion cysts. A case report, J Reprod Med., 45, 159
- 10.1093/jnci/88.24.1790 · DOI
- 10.1074/jbc.270.23.14184 · DOI · Paper page
- Wong KK, 1993, Identification of differentially expressed RNA in human ovarian carcinoma cells by arbitrarily primed PCR fingerprinting of total RNA, Intl J Oncol., 3, 13
- 10.1038/sj.onc.1201769 · DOI · Paper page
- 10.1038/sj.onc.1202649 · DOI · Paper page
- 10.1038/sj.onc.1203853 · DOI
- 10.1006/geno.1996.0185 · DOI
- 10.1006/geno.2000.6383 · DOI
- 10.1038/sj.onc.1201678 · DOI
- 10.1074/jbc.M101820200 · DOI
- Kirkegaard LJ, 1998, Image cytometric measurement of nuclear proliferation markers (MIB‐1, PCNA) in astrocytomas. Prognostic significance, Am J Clin Pathol., 109, 69, 10.1093/ajcp/109.1.69 · DOI
- 10.1007/BF02632043 · DOI
- 10.1210/er.22.2.255 · DOI
- 10.1006/gyno.1998.5094 · DOI
- 10.1002/(SICI)1097-0320(19960915)26:3<198::AID-CYTO3>3.0.CO;2-B · DOI
- 10.1093/ajcp/96.4.444 · DOI
- 10.1007/BF01192204 · DOI
- 10.1006/gyno.1995.1026 · DOI
- Marx D, 1997, Mib‐1 evaluated proliferative activity in ovarian cancer with respect to prognostic significance, Anticancer Res., 17, 775
- 10.1016/0092-8674(89)90407-8 · DOI · Paper page
- 10.1101/gad.7.3.441 · DOI · Paper page
- 10.1038/39607 · DOI · Paper page
- 10.1016/S0896-6273(00)80936-8 · DOI
- 10.1016/S0092-8674(00)80782-5 · DOI · Paper page
- 10.1074/jbc.M106158200 · DOI · Paper page
- 10.1074/jbc.M105009200 · DOI
- Kuwashima Y, 1995, Basement membrane status in undifferentiated carcinomas of the ovary. Immunohistochemical distribution of type IV collagen and laminin, Eur J Gynaecol Oncol., 16, 181
- 10.1097/00000478-199205000-00009 · DOI
- Crawford HC, 1994, Tumor and stromal expression of matrix metalloproteinase and their role in tumor progression, Invasion Metastasis., 14, 234
- 10.1002/ijc.2910580110 · DOI
- 10.1002/ijc.2910560415 · DOI
- 10.1006/gyno.2000.5806 · DOI
- 10.1002/ijc.2910550119 · DOI
- Mok SC, 1996, SPARC, an extracellular matrix protein with tumor‐suppressing activity in human ovarian epithelial cells, Oncogene., 12, 1895
- 10.1038/sj.onc.1201385 · DOI
- Skubitz APN, 1996, Expression of _6 and _4 integrins in serous ovarian carcinoma correlates with expression of the basement membrane protein laminin, Am J Pathol., 148, 1445
- 10.1097/00004347-199901000-00007 · DOI
- 10.1126/science.7531366 · DOI
- 10.1242/dev.117.4.1183 · DOI
- 10.1016/0092-8674(75)90188-9 · DOI
- 10.1016/0039-128X(89)90040-8 · DOI
Cited by
Sorted by citations
Singer, G., Stöhr, R., Cope, L., Dehari, R., Hartmann, A., Cao, D.-F., Wang, T.-L., Kurman, R. J., & Shih, I.-M. (2005) · American Journal of Surgical Pathology · doi:10.1097/01.pas.0000146025.91953.8d · Cited by 408
Endocytosis and Physiology: Insights from Disabled-2 Deficient Mice
Tao, W., Moore, R., Smith, E. R., & Xu, X.-X. (2016) · Frontiers in Cell and Developmental Biology · doi:10.3389/fcell.2016.00129 · Cited by 43
Self-citation
Metadata
- Authors
- Yang, D., Smith, E. R., Cohen, C., Wu, H., Patriotis, C., Godwin, A. K., Hamilton, T. C., & Xu, X.
- Venue
- Cancer
- Publisher
- Wiley
- Published
- 2002-04-25
- Volume
- 94
- Issue
- 9
- Pages
- 2380-2392
- ISSN
- 0008-543X
- 1097-0142
- Cited by
- 67
- References
- 2
- Language
- en
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review